Neutralising antibodies against interferon beta in multiple sclerosis

Lancet. 2004 Jan 10;363(9403):166-7; author reply 168-9. doi: 10.1016/S0140-6736(03)15275-0.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies / immunology*
  • Antibody Formation / immunology
  • Cohort Studies
  • Disease Progression
  • Humans
  • Immunologic Factors / immunology*
  • Immunologic Factors / therapeutic use*
  • Interferon-beta / immunology*
  • Interferon-beta / therapeutic use*
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / immunology
  • Neutralization Tests / statistics & numerical data
  • Patient Selection
  • Randomized Controlled Trials as Topic
  • Research Design / standards
  • Treatment Outcome

Substances

  • Antibodies
  • Immunologic Factors
  • Interferon-beta